Chemical Structure : Lumiracoxib
CAS No.: 220991-20-8
Catalog No.: PC-20195Not For Human Use, Lab Use Only.
Lumiracoxib (COX-189) is a highly selective COX-2 inhibitor with IC50 of 0.14 uM in COX-2-expressing dermal fibroblasts, inhibits purified COX-2 with Ki of 0.06 uM, 50-fold selectivity over COX-1 (Ki=3 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $38 | In stock | |
25 mg | $68 | In stock | |
50 mg | $118 | In stock | |
100 mg | $188 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lumiracoxib (COX-189) is a highly selective COX-2 inhibitor with IC50 of 0.14 uM in COX-2-expressing dermal fibroblasts, inhibits purified COX-2 with Ki of 0.06 uM, 50-fold selectivity over COX-1 (Ki=3 uM).
Lumiracoxib shows no inhibition of COX-1 at concentrations up to 30 microM (HEK 293 cells transfected with human COX-1).
Lumiracoxib shows IC50 of 0.13 uM a human whole blood assay, 515 fold over COX-1.
Ex vivo, lumiracoxib inhibited COX-2-derived production of prostaglandin E(2) (PGE(2)) in the lipopolysaccharide-stimulated rat air pouch with an ID(50) value of 0.24 mg kg(-1).
Lumiracoxib showed dose-dependent effect in rat models of hyperalgesia, oedema, pyresis and arthritis.
M.Wt | 293.72 | |
Formula | C15H13ClFNO2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid |
1. Ronald Esser, et al. Br J Pharmacol. 2005 Feb;144(4):538-50.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright